IDEA #3SHL58
Blm10/PA200, a ubiquitin-independent 20S proteasomal activator and unique target for single or combined anticancer chemotherapy
For more information or to license this innovation:
Log In
to view the innovation's details
Sign Up
with discount code "ECOS"
